The tech market in the United States, particularly in San Francisco, is growing at lightning speed rates and simultaneously delivering immaculate business transformations. The San Francisco Bay Area ...

Clinical Congress 2024, one of the largest global meetings of surgeons, takes place next week from October 19-22 in San ...

Collaborations with Merck, Vaxcyte, and Astellas Pharma could ... company founded in 2003 and headquartered in South San Francisco. STRO develops antibody-drug conjugates [ADCs] for oncology ...

Xaira Therapeutics today announced the appointment of Dr. Debbie Law and Julia Tran to its C-suite. Law will serve as chief ...

It has shifted commercial manufacturing off Genentech's South San Francisco campus ... Genentech also makes some drugs there for Merck & Co. Inc. Lonza will phase out manufacturing of those ...

Improving global diversity of global datasets will enable researchers to better serve underrepresented groups and advance our ...

joked as she mentioned her colleagues in San Francisco who are working on sanitary sewer overflows. Williams said it’s a lot easier to garner support from the public, media, and funders to ...

Even so, until there is evidence to suggest significant benefit in patients enrolled over 3 months after a WHF event, HFSA immediate past-president John Teerlink, MD, of San Francisco Veterans ...

of the University of California San Francisco, at the American Society for Radiation Oncology (ASTRO) meeting in Washington. "De-intensification studies, going forward, must evolve to be more ...

The small-molecule PIKfyve inhibitor – called VRG50635 – has been administered to the first subject in the phase 1 trial involving healthy volunteers, according to the San Francisco-based ...

Jesse is Principal and South San Francisco Office Head at GCI General ... Nordisk, Corteva, Merck, GSK, AstraZeneca, and Pfizer. What’s next for the Peninsula's life science real estate market?

Sanofi is tapping San Francisco-based Atomwise for a new AI ... some of the biggest names in pharma and medicine, including Merck & Co, Eli Lilly, and AbbVie. In 2019 they struck a major deal ...